AKT1 and ovarian cancer: Yang et al. [79] found that the expression of miR-214 and miR-150 is abnormally up-regulated in ovarian cancer, which can inhibit the target gene PTEN, down-regulate the PTEN protein, and initiate the protein kinase B (AKT) pathway.